Intra-aortic balloon pump implantation does not affect long-term survival after isolated CABG in patients with acute...

Area of Science:

• Cardiology
• Cardiac Surgery
• Medical Devices

Background:

• Intra-aortic balloon pump (IABP) is a critical support therapy for patients with heart failure undergoing coronary artery bypass grafting (CABG).
• The timing of IABP implantation (preoperative vs. intraoperative) is a key factor influencing patient outcomes.
• Understanding this impact is crucial for managing high-risk patients with acute myocardial infarction (AMI).

Purpose of the Study:

• To analyze the relationship between IABP implantation timing and patient survival.
• To evaluate the impact of preoperative versus intraoperative IABP placement on early, mid-term, and long-term survival in AMI patients undergoing emergent CABG.
• To assess the overall survival rates in patients receiving IABP support during emergent CABG for NSTEMI and STEMI.

Main Methods:

• A retrospective analysis of 472 patients with AMI (NSTEMI and STEMI) who underwent emergent CABG.
• 158 patients received IABP support, with 57 receiving preoperative and 101 receiving intraoperative implantation.
• In-hospital and follow-up survival (mean 37 months) were the primary endpoints.

Main Results:

• Overall in-hospital mortality was 17.1%, with no significant difference between preoperative (17.6%) and intraoperative (16.8%) IABP groups.
• Mid- and long-term survival rates at 1, 3, and 5 years were comparable between the two IABP timing groups.
• No statistically significant differences were observed in survival outcomes based on IABP implantation timing.

Conclusions:

• CABG with IABP support in high-risk AMI patients is associated with acceptable in-hospital and long-term survival.
• The decision for IABP placement should be individualized based on preoperative status and intraoperative course.
• IABP placement timing does not appear to significantly affect long-term outcomes after isolated CABG in AMI patients.